Coya Therapeutics Presents ALS Biomarker Data at Society of

4-Hydroxynonenal levels strongly correlate with rate of Amyotrophic Lateral Sclerosis disease progression and survival of patients from onset and diagnosis to death


4-HNE levels may serve as a...

Related Keywords

United States , Texas , Houston , Stanley Appel , Fred Grossman , Jason Thonhoff , David Beers , Nasdaq , National Institutes Of Health , Coya Therapeutics Inc , Houston Methodist Research Institute , Research Professor Of Neurology , Society Of Neuroimmune Pharmacology Conference , Coya Therapeutics , Scientific Advisory Board , Associate Research Professor , Houston Methodist , Neuroimmune Pharmacology , Chief Medical Officer , Frontotemporal Dementia , About Amyotrophic Lateral , Lou Gehrig , Amyotrophic Lateral Sclerosis ,